Pharmaceutical Leaders & Regulatory Experts Come Together for Industry-Critical Discussions

14 August, 2019

ISPE announced its featured speakers for the 2019 ISPE Annual Meeting & Expo. Taking place 27–30 October 2019 in Las Vegas, Nevada, this signature event brings together top pharmaceutical industry and regulatory leaders offering compelling and enlightening presentations and interactive discussions on industry-critical technical developments.


Featured Industry and Regulatory Speakers:

William Anderson
Chief Executive Officer
Roche Pharmaceuticals

William Anderson serves as Head of North American Commercial Operations and Director at Genentech, Inc. Anderson has been CEO of Roche Pharmaceuticals at Roche Holding AG since 1 January 2019. He offers expertise in chemical engineering and management including a Master of Science from MIT.


David Churchward
Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector)
MHRA

David Churchward serves as an Expert GMDP Inspector for the Medicines and Healthcare products Regulatory Agency (MHRA). He has been a GMDP inspector with the UK Medicines and Healthcare Products Regulatory Agency since 2004. In his current role, Churchward is responsible for providing technical and professional leadership to the MHRA’s team of 30 GMDP inspectors.


John Crowley
Chairman & CEO, Co-Founder
Amicus Therapeutics

In John Crowley’s drive to find a cure for Pompe disease, he left his position at Bristol-Myers Squibb and became the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for the disease. Novazyme was acquired by Genzyme Corporation and John continued in a lead development role as Senior VP, Genzyme Therapeutics.


Joey Gouws, PhD
Group Lead, Inspection Services, Prequalification Team
World Health Organization

Dr. Joey Gouws is the Group Lead of Inspections of the World Health Organization Prequalification Program, responsible for the oversight of all inspections relating to medicines, vaccines, medical devices and vector control products. Her working experience includes retail pharmacy, hospital pharmacy, and managing the regulatory affairs department for Bayer.


Placeholder Person Graphic
Pierre-Alain Ruffieux, PhD
Head of Global Pharma Technical Operations
F. Hoffmann-La Roche, Ltd.

Dr. Pierre-Alain Ruffieux is Global Head of Quality and Compliance for Roche Pharma Technical Operations, responsible for all Pharmaceutical Quality and GMP compliance activities. He brings more than 20 years of experience in technical development, manufacturing and quality. He was most recently a member of the Pharma Executive Committee at Novartis.


The ISPE Annual Meeting & Expo draws global pharmaceutical professionals at all levels of the industry, from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies. The unparalleled education program provides attendees with technical sessions on the latest developments in supply chain, facilities & equipment, information systems, process development & manufacturing, quality systems & regulatory oversight, and cutting-edge industry innovations. This year’s event will focus on modernization, globalization, and transformation in pharmaceutical science and manufacturing across the globe.

Learn More & Register